TesaIpa is a research peptide blend combining tesamorelin and ipamorelin for laboratory investigation of growth hormone–related signaling pathways. Tesamorelin is a synthetic analog of growth hormone-releasing hormone (GHRH), while ipamorelin is a growth hormone secretagogue associated with ghrelin receptor (GHSR) signaling. The combination provides researchers with a defined research material for studying two distinct signaling inputs involved in the regulation of growth hormone release. TesaIpa is supplied by Helix Bio strictly for research and laboratory use and is not intended for human or veterinary administration.
HPLC certified
Independent analysis
Highest standard
Full traceability
What Is TesaIpa?
TesaIpa refers to a peptide combination containing tesamorelin and ipamorelin. The two compounds are associated with different components of growth hormone signaling:
Tesamorelin has been investigated for its ability to influence endogenous growth hormone pulsatility, while ipamorelin has been studied as a selective growth hormone secretagogue. Research involving the two compounds can therefore examine complementary mechanisms within the growth hormone axis.
Importantly, the presence of tesamorelin in this research blend should not be confused with FDA-approved prescription tesamorelin products. FDA records identify tesamorelin as the active substance in Egrifta products, but a research-use-only material from Helix Bio is a separate product and is not an FDA-approved drug.
TesaIpa contains two research peptides:
Tesamorelin: A GHRH analog used in research involving GHRH receptor activity, pituitary signaling, growth hormone secretion, and related endocrine pathways.
Ipamorelin: A growth hormone secretagogue studied in connection with the ghrelin receptor, also known as the growth hormone secretagogue receptor (GHSR).
The exact blend ratio and total quantity should always be confirmed from the specific product label and batch documentation supplied with the material.
TesaIpa is intended for laboratory research where investigators need to examine the interaction between different growth hormone secretagogue pathways.
Research may focus on:
Published research has shown that tesamorelin can influence endogenous GH pulsatility and IGF-I levels in controlled experimental settings, making the compound relevant to research on the regulation of the growth hormone axis.
Important Product Distinction
TesaIpa is a research-use-only peptide blend. It should not be represented as a finished pharmaceutical, dietary supplement, or approved therapeutic combination.
Helix Bio states that its products are intended exclusively for research and laboratory purposes and are not intended for ingestion, injection, diagnosis, treatment, cure, or prevention of disease.
Researchers studying peptide signaling often need materials with clearly defined identities and supporting analytical documentation. TesaIpa provides a way to investigate two different signaling inputs associated with growth hormone regulation within a single research material.
Helix Bio's catalog describes a quality-control process involving HPLC purity analysis, mass spectrometry identity confirmation, and batch-specific Certificates of Analysis. These records can help researchers evaluate the identity and stated purity of the material before incorporating it into a laboratory workflow.
The combination is particularly relevant when the research question involves comparing or examining the relationship between GHRH-mediated and GHSR-mediated signaling.
TesaIpa is intended for qualified users conducting legitimate scientific or laboratory research, including:
It is not intended for consumers seeking personal health, cosmetic, performance, weight-management, or therapeutic applications.
Knowledge Base
Knowledge Base
Knowledge Base
Knowledge Base
Knowledge Base
Knowledge Base
Knowledge Base
Knowledge Base
Knowledge Base
Knowledge Base
Knowledge Base
Knowledge Base
Cyclic peptides resist protease degradation and reach undruggable targets. Learn how peptide cyclization works and why stability improves. Explore the research.
How continuous flow, automation, enzymatic routes and AI are changing peptide synthesis technology, and what it means for research peptide purity and supply.
AI now designs peptides from scratch. How AlphaFold 3, RFdiffusion and protein language models reshaped peptide discovery in 2026 — research use only.
